Phone (Mobile)
+1 857 ❅❅❅ ❅❅❅❅
Phone (Mobile)
Phone (HQ)
(617) 916-5445
Phone (HQ)
❅❅❅❅❅@candeltx.com
❅❅❅❅❅@gmail.com
Office Address (HQ)
117 Kendrick St Ste 450, Needham, Massachusetts, 02494, United States
Office Address (HQ)
Get 10 Free Leads on us
Use our Chrome Extension & instantly connect with prospects
Charles Schoch
Charles Schoch
Interim Chief Financial Officer
Candel Therapeutics
Profile privacy
Connect with Charles Schoch, Now
According to Datanyze information, these are Charles Schoch's contact details. Reveal the hidden information below for FREE!
Work Biography for Charles Schoch, Candel Therapeutics
Charles Schoch works as a Interim Chief Financial Officer at Candel Therapeutics, which is a Business Services company with an estimated 38 employees; and founded in 1999. They are part of the Finance Executive team within the C-Suite Department and their management level is VP-Level. Charles graduated from Northeastern University and is currently based in Needham, United States. They used to work at PwC and Harmonix Music Systems and have used the following emails: @candeltx.com, @pwc.com, @corbuspharma.com.
Quickly connect with Charles before someone else does! 👏
Previous Work Experience
Charles Schoch's career began less then a year ago. Prior to joining Candel Therapeutics, Charles worked at 6 companies.
Corbus Pharmaceuticals
Corporate Controller
PwC
Manager
Harmonix Music Systems
Consultant - Accounting
Biops LLC
Owner
Codon Devices
Manager, Purchasing Lab & Facility
Constellation Pharmaceuticals
Consultant
Education
Bachelor of Science
Elon University
Master of Business Administration
Northeastern University
Charles's Workplace
Candel Therapeutics
117 Kendrick St Ste 450, Needham, Massachusetts, 02494, United States
38
$8.9 M
Business Services, Research & Development, Business Services, Manufacturing, Pharmaceuticals, Research & Development
Get Full Profile Access
Ice Breakers
Imagine you could know all about Candel Therapeutics - Charles Schoch’s company, before you contact them. Warm up a cold prospect with Datanyze icebreakers
Charles’s company in the news
Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025
April 23, 2025
Candel Therapeutics Announces Publication of Phase 1b Clinical Trial Data on the Combination of CAN-2409 and Nivolumab plus Standard of Care in Newly Diagnosed High-Grade Glioma Patients
April 1, 2025
Candel Therapeutics Reports Both Prolonged Median Overall Survival and Long Tail of Survival in Phase 2a Clinical Trial of CAN-2409 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment
March 26, 2025
See more
Insights to Break the Ice
In your first interaction
Charles is located in United States
Candel Therapeutics’s Funding
Last funding
$23M
April 3, 2019
Total raised
$65M
Work Colleague
See Charles Schoch's coworkers out of Candel Therapeutics's 38 employees
| Name & Title | Contact Info | |
|---|---|---|
 Ileen Winick Chief People Officer |
| Reveal for Free |
Garrett Nichols Chief Medical Officer |
| Reveal for Free |
Seshu Tyagarajan Chief Technical and Development Officer |
| Reveal for Free |
Kristin Kennedy Corporate Controller |
| Reveal for Free |
Abigail Bracha Vice President, Corporate Development & Strategy |
| Reveal for Free |
Luis Aguilar Clinical Operations Vice President, Business | Reveal for Free | |
Andrea Manzanera Vice President, Clinical Research & Pharmacovigilance |
| Reveal for Free |
Steve Graham Interim Chief Financial Officer |
| Reveal for Free |
What company does Charles Schoch work for?
What is Charles Schoch’s title in Candel Therapeutics?
What is Charles Schoch’s email & phone number?
Where is Charles Schoch located?
What is Charles Schoch’s headquarters phone number?
Where did Charles Schoch go to college?
Start with Datanyze For Free!
Find your B2B customer within minutes using affordable, accurate contact data from Datanyze
Try it free
